Mersana Therapeutics

+$0.24 (+2.80%) As of 5:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for cancer patients with significant unmet need. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.

CEO
Anna Protopapas
Employees
110
Headquarters
Cambridge, Massachusetts
Founded
2001

MRSN Key Statistics

Market Cap
632.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
852.25K
High Today
$8.89
Low Today
$8.57
Open Price
$8.59
Volume
466.27K
52 Week High
$29.09
52 Week Low
$8.03

MRSN Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure